Global General Anesthetic for Surgery Market Research Report 2025

Publication ID:

PB505252054

Publication Date:

May 22, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for General Anesthetic for Surgery was valued at US$ 4182 million in the year 2024 and is projected to reach a revised size of US$ 5302 million by 2031, growing at a CAGR of 3.5% during the forecast period.
General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.
The general anesthetic for surgery market is primarily driven by the increasing number of surgical procedures performed globally and the growing demand for safe and effective anesthesia to ensure patient comfort and successful surgical outcomes. General anesthesia plays a crucial role in inducing a reversible state of unconsciousness and analgesia during surgery, allowing surgeons to perform complex procedures with minimal patient discomfort. Moreover, advancements in anesthesia delivery systems and monitoring technologies contribute to the market"s growth by enhancing anesthesia administration precision and patient safety. However, the market also faces challenges, including the potential for adverse reactions and complications associated with general anesthesia, such as postoperative nausea and vomiting (PONV) or rare anesthetic-related reactions. Ensuring patient safety and minimizing the risk of adverse events remain key challenges for healthcare providers and anesthesiologists. Additionally, the availability and accessibility of anesthesia services in remote or underserved regions can be limited, hindering access to surgical care for some patients.
Report Scope
This report aims to provide a comprehensive presentation of the global market for General Anesthetic for Surgery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding General Anesthetic for Surgery.
The General Anesthetic for Surgery market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global General Anesthetic for Surgery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the General Anesthetic for Surgery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang
Segment by Type
Propofol
Sevoflurane
Remifentanil
Etomidate
Isoflurane
Other
Segment by Application
Intravenous Anesthetics
Inhalational Anesthetics
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of General Anesthetic for Surgery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of General Anesthetic for Surgery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 General Anesthetic for Surgery Market Overview
1.1 Product Definition
1.2 General Anesthetic for Surgery by Type
1.2.1 Global General Anesthetic for Surgery Market Value Comparison by Type (2024 VS 2031)
1.2.2 Propofol
1.2.3 Sevoflurane
1.2.4 Remifentanil
1.2.5 Etomidate
1.2.6 Isoflurane
1.2.7 Other
1.3 General Anesthetic for Surgery by Application
1.3.1 Global General Anesthetic for Surgery Market Value by Application (2024 VS 2031)
1.3.2 Intravenous Anesthetics
1.3.3 Inhalational Anesthetics
1.4 Global General Anesthetic for Surgery Market Size Estimates and Forecasts
1.4.1 Global General Anesthetic for Surgery Revenue 2020-2031
1.4.2 Global General Anesthetic for Surgery Sales 2020-2031
1.4.3 Global General Anesthetic for Surgery Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 General Anesthetic for Surgery Market Competition by Manufacturers
2.1 Global General Anesthetic for Surgery Sales Market Share by Manufacturers (2020-2025)
2.2 Global General Anesthetic for Surgery Revenue Market Share by Manufacturers (2020-2025)
2.3 Global General Anesthetic for Surgery Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of General Anesthetic for Surgery, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of General Anesthetic for Surgery, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of General Anesthetic for Surgery, Product Type & Application
2.7 Global Key Manufacturers of General Anesthetic for Surgery, Date of Enter into This Industry
2.8 Global General Anesthetic for Surgery Market Competitive Situation and Trends
2.8.1 Global General Anesthetic for Surgery Market Concentration Rate
2.8.2 The Global 5 and 10 Largest General Anesthetic for Surgery Players Market Share by Revenue
2.8.3 Global General Anesthetic for Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global General Anesthetic for Surgery Market Scenario by Region
3.1 Global General Anesthetic for Surgery Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global General Anesthetic for Surgery Sales by Region: 2020-2031
3.2.1 Global General Anesthetic for Surgery Sales by Region: 2020-2025
3.2.2 Global General Anesthetic for Surgery Sales by Region: 2026-2031
3.3 Global General Anesthetic for Surgery Revenue by Region: 2020-2031
3.3.1 Global General Anesthetic for Surgery Revenue by Region: 2020-2025
3.3.2 Global General Anesthetic for Surgery Revenue by Region: 2026-2031
3.4 North America General Anesthetic for Surgery Market Facts & Figures by Country
3.4.1 North America General Anesthetic for Surgery Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America General Anesthetic for Surgery Sales by Country (2020-2031)
3.4.3 North America General Anesthetic for Surgery Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe General Anesthetic for Surgery Market Facts & Figures by Country
3.5.1 Europe General Anesthetic for Surgery Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe General Anesthetic for Surgery Sales by Country (2020-2031)
3.5.3 Europe General Anesthetic for Surgery Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific General Anesthetic for Surgery Market Facts & Figures by Region
3.6.1 Asia Pacific General Anesthetic for Surgery Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific General Anesthetic for Surgery Sales by Region (2020-2031)
3.6.3 Asia Pacific General Anesthetic for Surgery Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America General Anesthetic for Surgery Market Facts & Figures by Country
3.7.1 Latin America General Anesthetic for Surgery Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America General Anesthetic for Surgery Sales by Country (2020-2031)
3.7.3 Latin America General Anesthetic for Surgery Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa General Anesthetic for Surgery Market Facts & Figures by Country
3.8.1 Middle East and Africa General Anesthetic for Surgery Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa General Anesthetic for Surgery Sales by Country (2020-2031)
3.8.3 Middle East and Africa General Anesthetic for Surgery Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global General Anesthetic for Surgery Sales by Type (2020-2031)
4.1.1 Global General Anesthetic for Surgery Sales by Type (2020-2025)
4.1.2 Global General Anesthetic for Surgery Sales by Type (2026-2031)
4.1.3 Global General Anesthetic for Surgery Sales Market Share by Type (2020-2031)
4.2 Global General Anesthetic for Surgery Revenue by Type (2020-2031)
4.2.1 Global General Anesthetic for Surgery Revenue by Type (2020-2025)
4.2.2 Global General Anesthetic for Surgery Revenue by Type (2026-2031)
4.2.3 Global General Anesthetic for Surgery Revenue Market Share by Type (2020-2031)
4.3 Global General Anesthetic for Surgery Price by Type (2020-2031)
5 Segment by Application
5.1 Global General Anesthetic for Surgery Sales by Application (2020-2031)
5.1.1 Global General Anesthetic for Surgery Sales by Application (2020-2025)
5.1.2 Global General Anesthetic for Surgery Sales by Application (2026-2031)
5.1.3 Global General Anesthetic for Surgery Sales Market Share by Application (2020-2031)
5.2 Global General Anesthetic for Surgery Revenue by Application (2020-2031)
5.2.1 Global General Anesthetic for Surgery Revenue by Application (2020-2025)
5.2.2 Global General Anesthetic for Surgery Revenue by Application (2026-2031)
5.2.3 Global General Anesthetic for Surgery Revenue Market Share by Application (2020-2031)
5.3 Global General Anesthetic for Surgery Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Aspen Pharma
6.1.1 Aspen Pharma Company Information
6.1.2 Aspen Pharma Description and Business Overview
6.1.3 Aspen Pharma General Anesthetic for Surgery Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Aspen Pharma General Anesthetic for Surgery Product Portfolio
6.1.5 Aspen Pharma Recent Developments/Updates
6.2 Fresenius-Kabi
6.2.1 Fresenius-Kabi Company Information
6.2.2 Fresenius-Kabi Description and Business Overview
6.2.3 Fresenius-Kabi General Anesthetic for Surgery Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Fresenius-Kabi General Anesthetic for Surgery Product Portfolio
6.2.5 Fresenius-Kabi Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Company Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie General Anesthetic for Surgery Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AbbVie General Anesthetic for Surgery Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 Baxter Healthcare
6.4.1 Baxter Healthcare Company Information
6.4.2 Baxter Healthcare Description and Business Overview
6.4.3 Baxter Healthcare General Anesthetic for Surgery Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Baxter Healthcare General Anesthetic for Surgery Product Portfolio
6.4.5 Baxter Healthcare Recent Developments/Updates
6.5 B.Braun
6.5.1 B.Braun Company Information
6.5.2 B.Braun Description and Business Overview
6.5.3 B.Braun General Anesthetic for Surgery Sales, Revenue and Gross Margin (2020-2025)
6.5.4 B.Braun General Anesthetic for Surgery Product Portfolio
6.5.5 B.Braun Recent Developments/Updates
6.6 Maruishi
6.6.1 Maruishi Company Information
6.6.2 Maruishi Description and Business Overview
6.6.3 Maruishi General Anesthetic for Surgery Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Maruishi General Anesthetic for Surgery Product Portfolio
6.6.5 Maruishi Recent Developments/Updates
6.7 Piramal
6.7.1 Piramal Company Information
6.7.2 Piramal Description and Business Overview
6.7.3 Piramal General Anesthetic for Surgery Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Piramal General Anesthetic for Surgery Product Portfolio
6.7.5 Piramal Recent Developments/Updates
6.8 Hikma Pharmaceuticals
6.8.1 Hikma Pharmaceuticals Company Information
6.8.2 Hikma Pharmaceuticals Description and Business Overview
6.8.3 Hikma Pharmaceuticals General Anesthetic for Surgery Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hikma Pharmaceuticals General Anesthetic for Surgery Product Portfolio
6.8.5 Hikma Pharmaceuticals Recent Developments/Updates
6.9 Yichang Humanwell
6.9.1 Yichang Humanwell Company Information
6.9.2 Yichang Humanwell Description and Business Overview
6.9.3 Yichang Humanwell General Anesthetic for Surgery Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Yichang Humanwell General Anesthetic for Surgery Product Portfolio
6.9.5 Yichang Humanwell Recent Developments/Updates
6.10 Nhwa
6.10.1 Nhwa Company Information
6.10.2 Nhwa Description and Business Overview
6.10.3 Nhwa General Anesthetic for Surgery Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Nhwa General Anesthetic for Surgery Product Portfolio
6.10.5 Nhwa Recent Developments/Updates
6.11 Hengrui
6.11.1 Hengrui Company Information
6.11.2 Hengrui Description and Business Overview
6.11.3 Hengrui General Anesthetic for Surgery Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hengrui General Anesthetic for Surgery Product Portfolio
6.11.5 Hengrui Recent Developments/Updates
6.12 Xi'an Libang
6.12.1 Xi'an Libang Company Information
6.12.2 Xi'an Libang Description and Business Overview
6.12.3 Xi'an Libang General Anesthetic for Surgery Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Xi'an Libang General Anesthetic for Surgery Product Portfolio
6.12.5 Xi'an Libang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 General Anesthetic for Surgery Industry Chain Analysis
7.2 General Anesthetic for Surgery Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 General Anesthetic for Surgery Production Mode & Process Analysis
7.4 General Anesthetic for Surgery Sales and Marketing
7.4.1 General Anesthetic for Surgery Sales Channels
7.4.2 General Anesthetic for Surgery Distributors
7.5 General Anesthetic for Surgery Customer Analysis
8 General Anesthetic for Surgery Market Dynamics
8.1 General Anesthetic for Surgery Industry Trends
8.2 General Anesthetic for Surgery Market Drivers
8.3 General Anesthetic for Surgery Market Challenges
8.4 General Anesthetic for Surgery Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂